AR045100A1 - Pirimidinas sustituidas, procedimiento para su obtencion y su uso en productos pesticidas - Google Patents

Pirimidinas sustituidas, procedimiento para su obtencion y su uso en productos pesticidas

Info

Publication number
AR045100A1
AR045100A1 ARP040102631A ARP040102631A AR045100A1 AR 045100 A1 AR045100 A1 AR 045100A1 AR P040102631 A ARP040102631 A AR P040102631A AR P040102631 A ARP040102631 A AR P040102631A AR 045100 A1 AR045100 A1 AR 045100A1
Authority
AR
Argentina
Prior art keywords
alkyl
alkenyl
alkynyl
cyano
alkoxy
Prior art date
Application number
ARP040102631A
Other languages
English (en)
Spanish (es)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of AR045100A1 publication Critical patent/AR045100A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP040102631A 2003-07-24 2004-07-23 Pirimidinas sustituidas, procedimiento para su obtencion y su uso en productos pesticidas AR045100A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10357714 2003-12-09

Publications (1)

Publication Number Publication Date
AR045100A1 true AR045100A1 (es) 2005-10-12

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102631A AR045100A1 (es) 2003-07-24 2004-07-23 Pirimidinas sustituidas, procedimiento para su obtencion y su uso en productos pesticidas

Country Status (30)

Country Link
US (1) US7375108B2 (https=)
EP (1) EP1651618B1 (https=)
JP (1) JP2006528603A (https=)
KR (1) KR20060052857A (https=)
AP (1) AP2157A (https=)
AR (1) AR045100A1 (https=)
AT (1) ATE350370T1 (https=)
AU (1) AU2004261373B8 (https=)
BR (1) BRPI0412891A (https=)
CA (1) CA2532718A1 (https=)
CO (1) CO5660292A2 (https=)
CR (1) CR8184A (https=)
CY (1) CY1106391T1 (https=)
DE (1) DE502004002570D1 (https=)
DK (1) DK1651618T3 (https=)
EA (1) EA010566B1 (https=)
EC (1) ECSP066278A (https=)
ES (1) ES2279395T3 (https=)
HR (1) HRP20070057T3 (https=)
IL (1) IL172848A0 (https=)
MA (1) MA27949A1 (https=)
MX (1) MXPA06000038A (https=)
NZ (1) NZ545103A (https=)
PE (1) PE20050882A1 (https=)
PL (1) PL1651618T3 (https=)
PT (1) PT1651618E (https=)
SI (1) SI1651618T1 (https=)
TW (1) TW200516075A (https=)
UY (1) UY28436A1 (https=)
WO (1) WO2005012261A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006005571A1 (de) * 2004-07-14 2006-01-19 Basf Aktiengesellschaft 2-substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
NZ610225A (en) * 2010-11-16 2015-08-28 Acetylon Pharmaceuticals Inc Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
WO2015054099A1 (en) 2013-10-08 2015-04-16 Acetylon Pharmaceuticals, Inc. Combinations of histone deacetylase inhibitors and either her2 inhibitors or pi3k inhibitors
US9278963B2 (en) 2013-10-10 2016-03-08 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
US10660890B2 (en) 2013-10-24 2020-05-26 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) Treatment of polycystic diseases with an HDAC6 inhibitor
WO2015084905A1 (en) 2013-12-03 2015-06-11 Acetylon Pharmaceuticals, Inc. Combinations of histone deacetylase inhibitors and immunomodulatory drugs
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
JP6952602B2 (ja) 2014-07-07 2021-10-20 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. ヒストンデアセチラーゼ阻害剤による白血病の治療
US9937174B2 (en) 2014-12-05 2018-04-10 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
US11813261B2 (en) 2016-04-19 2023-11-14 Acetylon Pharmaceuticals, Inc. HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic lymphocytic leukemia
JP6976577B2 (ja) * 2016-07-20 2021-12-08 国立大学法人東北大学 PPARαアゴニストを含有する、肺高血圧症の予防又は治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004503542A (ja) 2000-06-13 2004-02-05 ビーエーエスエフ アクチェンゲゼルシャフト 殺真菌性5−フェニル置換2−(シアノアミノ)ピリミジン誘導体
EA007719B1 (ru) * 2001-03-15 2006-12-29 Басф Акциенгезельшафт 5-фенилпиримидины, способ и промежуточные продукты для их получения и их применение для борьбы с фитопатогенными грибами
NZ533265A (en) * 2001-11-19 2006-05-26 Basf Ag 5-Phenylpyrimidines, their preparation, compositions comprising them and their use

Also Published As

Publication number Publication date
CA2532718A1 (en) 2005-02-10
HRP20070057T3 (hr) 2007-07-31
SI1651618T1 (sl) 2007-06-30
EP1651618B1 (de) 2007-01-03
PT1651618E (pt) 2007-03-30
UY28436A1 (es) 2005-02-28
AP2157A (en) 2010-09-13
US20070105873A1 (en) 2007-05-10
ATE350370T1 (de) 2007-01-15
EA010566B1 (ru) 2008-10-30
KR20060052857A (ko) 2006-05-19
US7375108B2 (en) 2008-05-20
JP2006528603A (ja) 2006-12-21
DK1651618T3 (da) 2007-05-14
EA200600212A1 (ru) 2006-08-25
MA27949A1 (fr) 2006-06-01
AP2006003497A0 (en) 2006-02-28
PE20050882A1 (es) 2005-12-01
TW200516075A (en) 2005-05-16
EP1651618A1 (de) 2006-05-03
ES2279395T3 (es) 2007-08-16
ECSP066278A (es) 2006-07-28
IL172848A0 (en) 2006-06-11
DE502004002570D1 (de) 2007-02-15
AU2004261373B2 (en) 2010-08-19
MXPA06000038A (es) 2006-03-21
NZ545103A (en) 2008-06-30
BRPI0412891A (pt) 2006-10-03
WO2005012261A1 (de) 2005-02-10
AU2004261373A1 (en) 2005-02-10
CO5660292A2 (es) 2006-07-31
CY1106391T1 (el) 2011-10-12
CR8184A (es) 2006-10-06
PL1651618T3 (pl) 2007-05-31
AU2004261373B8 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
AR045100A1 (es) Pirimidinas sustituidas, procedimiento para su obtencion y su uso en productos pesticidas
AR043014A1 (es) Amino-1,3,5-triazinas n-sustituidas con radicales biciclicos quirales, procedimiento para su preparacion, composiciones de las mismas, y su uso como herbicidas y reguladores del crecimiento de las plantas
AR063331A1 (es) Derivados de biaril eter urea y composiciones farmaceuticas
AR072576A1 (es) Metodo para la represion de malezas en un cesped
AR052903A1 (es) Compuestos de bis arilo y heteroarilo sustituidos como antagonistas selectivos de 5ht2a, composiciones farmaceuticas que los contienen y su empleo en el tratamiento de trastornos del sueno.
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
AR035617A1 (es) Compuestos derivados de fenetanolamina, combinaciones y formulaciones farmaceuticas de los mismos, proceso para su preparacion, su uso en la preparacion de medicamentos para el tratamiento o profilaxis de una condicion clinica para la cual se indica un agonista beta2 adreno-receptor e intermediarios
AR069326A1 (es) Derivados bis-(sulfonilamino), proceso de preparacion, composiciones farmaceuticas que los contienen y su uso en terapia.
AR072839A1 (es) Derivados adamantil diamida y usos de los mismos
AR064471A1 (es) Macrociclos inhibidores selectivos del factor de coagulacion viia, composiciones farmaceuticas que los comprenden y uso de los mismos como agentes anticoagulantes.
AR063151A1 (es) Inhibidores de metaloproteasas de matriz
AR065015A1 (es) Derivados de antranilamida, composiciones farmaceuticas que los contienen, y usos para el tratamiento del cancer
AR065425A1 (es) Derivados fungicidas de n-(3-fenilpropil)-carboxamida
AR033379A1 (es) Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR063139A1 (es) Inhibidores de metaloproteasas derivados de heterociclos. composiciones farmaceuticas.
AR045767A1 (es) Sulfonamidas como agentes fitosanitarios
AR084317A1 (es) 6-(2-aminofenil)-picolinatos y su uso como herbicidas
NO20092372L (no) Substituerte acetofenoner anvendelige som PDE4-inhibitorer
AR063636A1 (es) Derivados de indol y de benzofurano-2-carboxamida
AR055041A1 (es) Tiadiazoles y oxadiazoles como inhibidores de la sintesis de leucotrienos. composiciones farmaceuticas.
AR061185A1 (es) Compuestos heterociclicos como inhibidores de hsp90. composiciones farmaceuticas.
AR046611A1 (es) Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo
AR049832A1 (es) Piridinas 2-sustituidas, procedimientos para su obtencion y el uso de las mismas para combatir hongos nocivos
AR039028A1 (es) Piridinil amidas biciclicas fusionadas y composiciones ventajosas de las mismas como fungicidas
AR054000A1 (es) Compuesto de n-(fenilpropil)-sulfonamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento, producto de combinacion que comprende dicho compuesto y metodo para prepararlo

Legal Events

Date Code Title Description
FG Grant, registration